Published in Diabetologia on April 26, 2013
Plasma levels of advanced glycation endproducts are associated with type 1 diabetes and coronary artery calcification. Cardiovasc Diabetol (2013) 0.89
LR-90 prevents methylglyoxal-induced oxidative stress and apoptosis in human endothelial cells. Apoptosis (2014) 0.88
Cardiovascular disease and type 1 diabetes: prevalence, prediction and management in an ageing population. Ther Adv Chronic Dis (2015) 0.75
Methylglyoxal-Glyoxalase 1 Balance: The Root of Vascular Damage. Int J Mol Sci (2017) 0.75
Curcumin inhibits advanced glycation end product‑induced oxidative stress and inflammatory responses in endothelial cell damage via trapping methylglyoxal. Mol Med Rep (2015) 0.75
Analysis of advanced glycation end products in the DHS Mind Study. J Diabetes Complications (2015) 0.75
Methylglyoxal-Derived Advanced Glycation Endproducts in Multiple Sclerosis. Int J Mol Sci (2017) 0.75
Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N Engl J Med (2001) 22.32
Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet (2010) 11.55
Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA (2008) 7.84
Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study. Lancet (1999) 4.81
Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ (1991) 4.46
Prevention of diabetic renal disease with special reference to microalbuminuria. Lancet (1995) 4.06
The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases. Eur J Epidemiol (2007) 3.81
The use of metformin in type 1 diabetes: a systematic review of efficacy. Diabetologia (2010) 3.20
Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet (1983) 3.01
Long-term renoprotective effect of nisoldipine and lisinopril in type 1 diabetic patients with diabetic nephropathy. Diabetes Care (2000) 2.97
Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol (Copenh) (1982) 2.75
Effect of antihypertensive treatment on kidney function in diabetic nephropathy. Br Med J (Clin Res Ed) (1987) 2.35
The Evaluation of Screening and Early Detection Strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the Finnish diabetes risk score for prediction of incident type 2 diabetes. Diabetologia (2010) 2.33
Predicted impact of extending the screening interval for diabetic retinopathy: the Scottish Diabetic Retinopathy Screening programme. Diabetologia (2013) 2.31
Effects of short-term treatment with metformin on serum concentrations of homocysteine, folate and vitamin B12 in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2003) 2.28
Diabetes, prediabetes and cancer mortality. Diabetologia (2010) 2.22
Common nonsynonymous substitutions in SLCO1B1 predispose to statin intolerance in routinely treated individuals with type 2 diabetes: a go-DARTS study. Clin Pharmacol Ther (2010) 2.22
Mechanisms of edema formation in myxedema--increased protein extravasation and relatively slow lymphatic drainage. N Engl J Med (1979) 2.21
Markers of inflammation are cross-sectionally associated with microvascular complications and cardiovascular disease in type 1 diabetes--the EURODIAB Prospective Complications Study. Diabetologia (2005) 2.16
Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia (2011) 2.12
Semi-automatic assessment of skin capillary density: proof of principle and validation. Microvasc Res (2013) 2.01
Predictors of mortality in insulin dependent diabetes: 10 year observational follow up study. BMJ (1996) 2.00
[Chronic renal disease as cardiovascular risk factor]. Ned Tijdschr Geneeskd (2008) 1.94
Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int (2000) 1.85
Is diabetic nephropathy an inherited complication? Kidney Int (1992) 1.79
Effects of rosuvastatin and atorvastatin on glycaemic control in Type 2 diabetes---the CORALL study. Diabet Med (2012) 1.75
Mortality in people with type 2 diabetes in the UK. Diabet Med (2006) 1.74
Effect of captopril on kidney function in insulin-dependent diabetic patients with nephropathy. Br Med J (Clin Res Ed) (1986) 1.68
Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database. Diabetologia (2006) 1.65
Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study. Diabet Med (1998) 1.61
CNS effects of sumatriptan and rizatriptan in healthy female volunteers. Cephalalgia (2002) 1.60
Apoptosis in myocardial ischaemia and infarction. J Clin Pathol (2002) 1.59
Increased serum adiponectin levels in type 1 diabetic patients with microvascular complications. Diabetologia (2005) 1.58
Insertion/deletion polymorphism in the angiotensin-I-converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia (1995) 1.57
In-training assessment: qualitative study of effects on supervision and feedback in an undergraduate clinical rotation. Med Educ (2006) 1.56
Hemodynamic factors in the genesis of diabetic microangiopathy. Metabolism (1983) 1.56
Remission and regression in the nephropathy of type 1 diabetes when blood pressure is controlled aggressively. Kidney Int (2001) 1.55
Exome sequencing-driven discovery of coding polymorphisms associated with common metabolic phenotypes. Diabetologia (2012) 1.55
A prospective study of glomerular filtration rate and arterial blood pressure in insulin-dependent diabetics with diabetic nephropathy. Diabetologia (1981) 1.53
Increased kidney size, glomerular filtration rate and renal plasma flow in short-term insulin-dependent diabetics. Diabetologia (1981) 1.53
Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes (1995) 1.51
Autonomic nervous function, arterial stiffness and blood pressure in patients with Type I diabetes mellitus and normal urinary albumin excretion. J Hum Hypertens (2004) 1.51
Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol (1999) 1.51
Rheumatoid arthritis versus diabetes as a risk factor for cardiovascular disease: a cross-sectional study, the CARRE Investigation. Ann Rheum Dis (2008) 1.50
C-reactive protein and complement depositions in human infarcted myocardium are more extensive in patients with reinfarction or upon treatment with reperfusion. Eur J Clin Invest (2004) 1.50
Increased blood pressure and erythrocyte sodium/lithium countertransport activity are not inherited in diabetic nephropathy. Diabetologia (1990) 1.49
Perivenous application of fibrin glue reduces early injury to the human saphenous vein graft wall in an ex vivo model. Eur J Cardiothorac Surg (2002) 1.48
All-cause mortality rates in patients with type 1 diabetes mellitus compared with a non-diabetic population from the UK general practice research database, 1992-1999. Diabetologia (2006) 1.47
Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. Diabetologia (1991) 1.47
Monitoring kidney function in diabetic nephropathy. Diabetologia (1994) 1.47
Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia (2005) 1.46
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy. Kidney Int (2000) 1.46
Progression of diabetic nephropathy. Kidney Int (2001) 1.46
Diabetic nephropathy and arterial hypertension. Diabetologia (1983) 1.45
Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial. Diabetologia (2008) 1.44
Oestrogen replacement therapy lowers plasma levels of asymmetrical dimethylarginine in healthy postmenopausal women. Clin Sci (Lond) (2003) 1.43
Both resistance- and endurance-type exercise reduce the prevalence of hyperglycaemia in individuals with impaired glucose tolerance and in insulin-treated and non-insulin-treated type 2 diabetic patients. Diabetologia (2011) 1.42
Five-year incidence of type 2 diabetes mellitus in patients with familial combined hyperlipidaemia. Neth J Med (2010) 1.42
Prevalence of microalbuminuria in children with type 1 (insulin-dependent) diabetes mellitus. Diabetologia (1986) 1.41
Effects of short-term treatment with metformin on markers of endothelial function and inflammatory activity in type 2 diabetes mellitus: a randomized, placebo-controlled trial. J Intern Med (2005) 1.40
Reduction in albuminuria predicts a beneficial effect on diminishing the progression of human diabetic nephropathy during antihypertensive treatment. Diabetologia (1994) 1.40
Beneficial impact of ramipril on left ventricular hypertrophy in normotensive nonalbuminuric NIDDM patients. Diabetes Care (1998) 1.40
Discontinuation of metformin in type 2 diabetes patients treated with insulin. Neth J Med (2002) 1.38
Cytokine activation during attacks of the hyperimmunoglobulinemia D and periodic fever syndrome. Blood (1995) 1.37
The losartan renal protection study--rationale, study design and baseline characteristics of RENAAL (Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan). J Renin Angiotensin Aldosterone Syst (2000) 1.35
Effectiveness of clinical rotations as a learning environment for achieving competences. Med Teach (2004) 1.35
Prolonged QTc interval predicts mortality in patients with Type 1 diabetes mellitus. Diabet Med (2001) 1.34
Brisk walking compared with an individualised medical fitness programme for patients with type 2 diabetes: a randomised controlled trial. Diabetologia (2008) 1.29
Individuals at increased coronary heart disease risk are characterized by an impaired microvascular function in skin. Eur J Clin Invest (2003) 1.28
Increased urinary albumin-excretion rate in benign essential hypertension. Lancet (1974) 1.28
Hyperglycaemia-induced impairment of endothelium-dependent vasorelaxation in rat mesenteric arteries is mediated by intracellular methylglyoxal levels in a pathway dependent on oxidative stress. Diabetologia (2010) 1.27
Plasmalogen biosynthesis in peroxisomal disorders: fatty alcohol versus alkylglycerol precursors. J Lipid Res (1988) 1.27
Acute reduction of arterial blood pressure reduces urinary albumin excretion in type 1 (insulin-dependent) diabetic patients with incipient nephropathy. Diabetologia (1986) 1.26
Insulin resistance in type 1 diabetes: what is 'double diabetes' and what are the risks? Diabetologia (2013) 1.26
Increased Nox2 expression in human cardiomyocytes after acute myocardial infarction. J Clin Pathol (2003) 1.25
Beneficial impact of spironolactone on nephrotic range albuminuria in diabetic nephropathy. Kidney Int (2006) 1.24
Short stature and diabetic nephropathy. BMJ (1995) 1.24